GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family

[Image: see text] Pan-BET inhibitors have shown profound efficacy in a number of in vivo preclinical models and have entered the clinic in oncology trials where adverse events have been reported. These inhibitors interact equipotently with the eight bromodomains of the BET family of proteins. To bet...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ACS Med Chem Lett
Huvudupphovsmän: Preston, Alex, Atkinson, Stephen J., Bamborough, Paul, Chung, Chun-wa, Gordon, Laurie J., Grandi, Paola, Gray, James R. J., Harrison, Lee A., Lewis, Antonia J., Lugo, David, Messenger, Cassie, Michon, Anne-Marie, Mitchell, Darren J., Prinjha, Rab K., Rioja, Inmaculada, Seal, Jon, Taylor, Simon, Thesmar, Pierre, Wall, Ian D., Watson, Robert J., Woolven, James M., Demont, Emmanuel H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Chemical Society 2020
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7429977/
https://ncbi.nlm.nih.gov/pubmed/32832027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.0c00247
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk